Tags:BioTechDefenseDrug
Developing cures for cancer through drugs that alter the body’s first line of defense, innate immunity.
Total raised: $9.5M

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
22.10.2019-$9.5M--

Mentions in press and media 115

DateTitleDescriptionCategoryAuthorSource
23.10.2019Daily fund...Reibus raised $3.25M; AllWork ...-Kristin Ka...vator.tv/n...
22.10.2019Intrepida ...---connect.or...
22.10.2019Intrepida ...---connect.or...
22.10.2019Intrepida ...Intrepida Bio, Inc., a San Die...USA-finsmes.co...
22.10.2019Intrepida ...---connect.or...
22.10.2019Intrepida ...---connect.or...
22.10.2019Intrepida ...---connect.or...
22.10.2019Intrepida ...---connect.or...
22.10.2019Intrepida ...---connect.or...
22.10.2019Intrepida ...---connect.or...
Show more